argenx SE (ARGX): Price and Financial Metrics
argenx SE (ARGX)
Today's Latest Price: $286.01 USD
Updated Dec 3 2:50pm
Add ARGX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ARGX Stock Summary
- With a price/sales ratio of 158.77, Argenx Se has a higher such ratio than 97.64% of stocks in our set.
- Over the past twelve months, ARGX has reported earnings growth of 640.7%, putting it ahead of 97.83% of US stocks in our set.
- Revenue growth over the past 12 months for Argenx Se comes in at 374.98%, a number that bests 98.1% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Argenx Se are DNLI, ZYME, BNTX, MEIP, and PRQR.
- Visit ARGX's SEC page to see the company's official filings. To visit the company's web site, go to www.argenx.com.
ARGX Stock Price Chart Interactive Chart >
ARGX Price/Volume Stats
| Current price | $286.01 | 52-week high | $291.23 |
| Prev. close | $287.89 | 52-week low | $103.75 |
| Day low | $284.74 | Volume | 171,293 |
| Day high | $290.72 | Avg. volume | 173,888 |
| 50-day MA | $264.70 | Dividend yield | N/A |
| 200-day MA | $211.74 | Market Cap | 13.44B |
argenx SE (ARGX) Company Bio
arGEN-X N.V., a clinical-stage biopharmaceutical company, focuses on creating and developing therapeutic antibodies for the treatment of cancer and autoimmune diseases. The company was founded in 2008 and is based in Breda, Netherlands.
Loading social stream, please wait...